Rubinstein, M. M., Sharma, M. R., Papadopoulos, K. P., Barretina-Ginesta, M., Garcia-Duran, C., Ponz-Sarvise, M., Redondo, A., Moreno, V., Uyar, D. S., Wampfler, J., Hess, D., Manso, L., Fuchs, J., Corne, E. D., Luong, N., Dozio, V., Tat, T., Crevel, F., Freixinos, V. R., Stathis, A. (2025). Debio 0123, a highly selective WEE1 inhibitor in adult patients with advanced solid tumors: A phase 1 dose escalation and expansion monotherapy study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5634